Repligen | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Agilent USD 410M 16M 2025-01
Align Technology USD 447.63M 22.66M 2025-03
Bio Techne USD 118.72M 7.35M 2024-12
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Bruker USD 247.3M 17.4M 2024-12
Charles River Laboratories USD 188.26M 946K 2024-12
Danaher USD 1.86B 165M 2025-03
Dentsply International USD 375M 13M 2024-12
Exact Sciences USD 485M 114.56M 2025-03
General Electric USD 876M 281M 2025-03
Henry Schein USD 737M 15M 2024-12
Illumina USD 263M 29M 2024-12
IQVIA Holdings USD 508M 55M 2025-03
Mettler Toledo International USD 242.8M 5.46M 2025-03
Myriad Genetics USD 136M 3.1M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Repligen USD 71.26M 10.93M 2025-03
Revvity USD 249.72M 5.9M 2025-03
Standard Biotools USD 37.59M 3.18M 2024-12
Thermo Fisher Scientific USD 1.72B 487M 2025-03
Waters USD 174.88M 1.61M 2025-03
West Pharmaceutical Services USD 88M 2.7M 2025-03



Repligen Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.